Alexei Repik will earn a couple of tens of millions of dollars in the US market


R-Pharm and the Russian Venture Company invested $ 4 million in the American company Bonti, which develops drugs for aesthetic medicine, and will receive up to $ 20 million when it is sold to the Irish giant Allergan.

Alexey Repik owes the Ministry of Health 387 million rubles


Veronika Skvortsova's office has already filed 16 lawsuits against the company R-Pharm.

FAS Russia suspected the Ministry of Health in collusion with the companies of Alexey Repik


Three antitrust cases have already been initiated against Alexey Repik's R-Pharm.

Alexey Repik continued expansion in the Russian market


The businessman bought a plant of accelerators for radiation therapy in Dubna (Moscow region).

"R-farm" did not pay for tablets


The company lost the dispute to Native.

Alexander Vinokurov seizes pharmacy business in Russia


The son-in-law of Foreign Minister Sergei Lavrov and the raider in combination intend to reshape the pharmacy business in Russia in his favor.

Ministry of Health denies collusion with Alexei Repik


The Ministry of Health of the Russian Federation responded to suspicions of the Federal Antimonopoly Service (FAS) in collusion with R-Pharm. The department does not understand which part of the antimonopoly legislation was violated, and the FAS verification is called biased.

Competitors set on Alexei Repik FAS Russia


Suddenly, the clear-sighted antimonopoly service suspected the Ministry of Health in unusually generous preferences for the company "R-Pharm."

It's better not to get sick in Russia


In Russia, the pharmaceutical market is being monopolized, which will lead to a sharp rise in prices for medicines for the population.

Kings of the state order - 2017: Forbes rating


The multi-billion government contracts are obtained by mysterious contractors without tenders. 

Why Moscow pays so dearly for medications


There's no competition in many tenders, so the orders are placed at the maximum price.